Publication | Closed Access

IgM peak independently predicts treatment-free survival in chronic lymphocytic leukemia and correlates with accumulation of adverse oncogenetic events

Hematological MalignancyMedicineMixed-phenotype Acute LeukemiaHematologyImmunologyPathologyTreatment-free SurvivalAdult T-cell Leukemia-lymphomaImmunotherapyOncologyIgm PeakAdverse Oncogenetic EventsCancer Research